Balyasny Asset Management LLC Xeris Biopharma Holdings, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.48 - $2.64 $161,771 - $288,565
-109,305 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.0 - $2.87 $179,754 - $257,946
89,877 Added 462.62%
109,305 $280,000
Q4 2021

Feb 14, 2022
BUY
$1.8 - $2.93 $34,970 - $56,924
19,428 New
19,428 $57,000

Others Institutions Holding XERS

# of Institutions
143
Shares Held
60M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $462M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email